Literature DB >> 22331615

Proteome and computational analyses reveal new insights into the mechanisms of hepatitis C virus-mediated liver disease posttransplantation.

Deborah L Diamond1, Alexei L Krasnoselsky, Kristin E Burnum, Matthew E Monroe, Bobbie-Jo Webb-Robertson, Jason E McDermott, Matthew M Yeh, Jose Felipe Golib Dzib, Nathan Susnow, Susan Strom, Sean C Proll, Sarah E Belisle, David E Purdy, Angela L Rasmussen, Kathie-Anne Walters, Jon M Jacobs, Marina A Gritsenko, David G Camp, Renuka Bhattacharya, James D Perkins, Robert L Carithers, Iris W Liou, Anne M Larson, Arndt Benecke, Katrina M Waters, Richard D Smith, Michael G Katze.   

Abstract

UNLABELLED: Liver transplant tissues offer the unique opportunity to model the longitudinal protein abundance changes occurring during hepatitis C virus (HCV)-associated liver disease progression in vivo. In this study, our goal was to identify molecular signatures, and potential key regulatory proteins, representative of the processes influencing early progression to fibrosis. We performed global protein profiling analyses on 24 liver biopsy specimens obtained from 15 HCV(+) liver transplant recipients at 6 and/or 12 months posttransplantation. Differentially regulated proteins associated with early progression to fibrosis were identified by analysis of the area under the receiver operating characteristic curve. Analysis of serum metabolites was performed on samples obtained from an independent cohort of 60 HCV(+) liver transplant patients. Computational modeling approaches were applied to identify potential key regulatory proteins of liver fibrogenesis. Among 4,324 proteins identified, 250 exhibited significant differential regulation in patients with rapidly progressive fibrosis. Patients with rapid fibrosis progression exhibited enrichment in differentially regulated proteins associated with various immune, hepatoprotective, and fibrogenic processes. The observed increase in proinflammatory activity and impairment in antioxidant defenses suggests that patients who develop significant liver injury experience elevated oxidative stresses. This was supported by an independent study demonstrating the altered abundance of oxidative stress-associated serum metabolites in patients who develop severe liver injury. Computational modeling approaches further highlight a potentially important link between HCV-associated oxidative stress and epigenetic regulatory mechanisms impacting on liver fibrogenesis.
CONCLUSION: Our proteome and metabolome analyses provide new insights into the role for increased oxidative stress in the rapid fibrosis progression observed in HCV(+) liver transplant recipients. These findings may prove useful in prognostic applications for predicting early progression to fibrosis.
Copyright © 2012 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22331615      PMCID: PMC3387320          DOI: 10.1002/hep.25649

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  42 in total

1.  Molecular pathways differentiate hepatitis C virus (HCV) recurrence from acute cellular rejection in HCV liver recipients.

Authors:  Ricardo Gehrau; Daniel Maluf; Kellie Archer; Richard Stravitz; Jihee Suh; Ngoc Le; Valeria Mas
Journal:  Mol Med       Date:  2011-04-20       Impact factor: 6.354

2.  Plasma metabolomic profile in nonalcoholic fatty liver disease.

Authors:  Satish C Kalhan; Lining Guo; John Edmison; Srinivasan Dasarathy; Arthur J McCullough; Richard W Hanson; Mike Milburn
Journal:  Metabolism       Date:  2010-04-27       Impact factor: 8.694

Review 3.  Pathogenesis of liver fibrosis.

Authors:  Virginia Hernandez-Gea; Scott L Friedman
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

4.  Oxidative stress and nutritional factors in hepatitis C virus-positive liver recipients, controls, and hepatitis C virus-positive nontransplant patients.

Authors:  J Madill; B Arendt; E Aghdassi; C Chow; M Guindi; G Therapondos; L Lilly; J Allard
Journal:  Transplant Proc       Date:  2010-06       Impact factor: 1.066

5.  Genomewide microRNA down-regulation as a negative feedback mechanism in the early phases of liver regeneration.

Authors:  Jingmin Shu; Betsy T Kren; Zhilian Xia; Phillip Y-P Wong; Lihua Li; Eric A Hanse; Michael X Min; Bingshan Li; Jeffrey H Albrecht; Yan Zeng; Subbaya Subramanian; Clifford J Steer
Journal:  Hepatology       Date:  2011-06-30       Impact factor: 17.425

6.  A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease.

Authors:  Michael L Washburn; Moses T Bility; Liguo Zhang; Grigoriy I Kovalev; Adam Buntzman; Jeffery A Frelinger; Walter Barry; Alexander Ploss; Charles M Rice; Lishan Su
Journal:  Gastroenterology       Date:  2011-01-13       Impact factor: 22.682

7.  Improving the efficiency of multidimensional scaling in the analysis of high-dimensional data using singular value decomposition.

Authors:  Christophe Bécavin; Nicolas Tchitchek; Colette Mintsa-Eya; Annick Lesne; Arndt Benecke
Journal:  Bioinformatics       Date:  2011-03-17       Impact factor: 6.937

8.  Combined statistical analyses of peptide intensities and peptide occurrences improves identification of significant peptides from MS-based proteomics data.

Authors:  Bobbie-Jo M Webb-Robertson; Lee Ann McCue; Katrina M Waters; Melissa M Matzke; Jon M Jacobs; Thomas O Metz; Susan M Varnum; Joel G Pounds
Journal:  J Proteome Res       Date:  2010-10-08       Impact factor: 4.466

9.  A systems view of epithelial-mesenchymal transition signaling states.

Authors:  Stuart Thomson; Filippo Petti; Izabela Sujka-Kwok; Peter Mercado; James Bean; Melissa Monaghan; Sean L Seymour; Gretchen M Argast; David M Epstein; John D Haley
Journal:  Clin Exp Metastasis       Date:  2010-12-31       Impact factor: 5.150

10.  Epigenetic modulation of the protein kinase A RIIα (PRKAR2A) gene by histone deacetylases 1 and 2 in human smooth muscle cells.

Authors:  Magdalena Karolczak-Bayatti; Andrew D Loughney; Stephen C Robson; G Nicholas Europe-Finner
Journal:  J Cell Mol Med       Date:  2011-01       Impact factor: 5.310

View more
  18 in total

1.  Metabolic Profiling of Formalin-Fixed Paraffin-Embedded Tissues Discriminates Normal Colon from Colorectal Cancer.

Authors:  Kota Arima; Mai Chan Lau; Melissa Zhao; Koichiro Haruki; Jonathan A Nowak; Marios Giannakis; Charles S Fuchs; Shuji Ogino; Keisuke Kosumi; Kosuke Mima; Mancang Gu; Juha P Väyrynen; Tyler S Twombly; Yoshifumi Baba; Kenji Fujiyoshi; Junko Kishikawa; Chunguang Guo; Hideo Baba; William G Richards; Andrew T Chan; Reiko Nishihara; Jeffrey A Meyerhardt
Journal:  Mol Cancer Res       Date:  2020-03-12       Impact factor: 5.852

2.  Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome.

Authors:  Eric G Meissner; David Wu; Anu Osinusi; Dimitra Bon; Kimmo Virtaneva; Dan Sturdevant; Steve Porcella; Honghui Wang; Eva Herrmann; John McHutchison; Anthony F Suffredini; Michael Polis; Stephen Hewitt; Ludmila Prokunina-Olsson; Henry Masur; Anthony S Fauci; Shyamasundaran Kottilil
Journal:  J Clin Invest       Date:  2014-07-01       Impact factor: 14.808

3.  Metabolic phenotyping for enhanced mechanistic stratification of chronic hepatitis C-induced liver fibrosis.

Authors:  Caroline J Sands; Indra N Guha; Michael Kyriakides; Mark Wright; Olaf Beckonert; Elaine Holmes; William M Rosenberg; Muireann Coen
Journal:  Am J Gastroenterol       Date:  2014-12-23       Impact factor: 10.864

4.  Topological analysis of protein co-abundance networks identifies novel host targets important for HCV infection and pathogenesis.

Authors:  Jason E McDermott; Deborah L Diamond; Courtney Corley; Angela L Rasmussen; Michael G Katze; Katrina M Waters
Journal:  BMC Syst Biol       Date:  2012-04-30

Review 5.  Proteomic approaches to analyzing hepatitis C virus biology.

Authors:  Florian Douam; Alexander Ploss
Journal:  Proteomics       Date:  2015-05-05       Impact factor: 3.984

6.  Hepatitis C virus treatment with direct-acting antivirals induces rapid changes in the hepatic proteome.

Authors:  Lauren E Ball; Bernice Agana; Susana Comte-Walters; Don C Rockey; Henry Masur; Shyam Kottilil; Eric G Meissner
Journal:  J Viral Hepat       Date:  2021-08-19       Impact factor: 3.728

7.  Opportunities in proteomics to understand hepatitis C and HIV coinfection.

Authors:  Eric G Meissner; Anthony F Suffredini; Shyamasundaran Kottilil
Journal:  Future Virol       Date:  2012-08       Impact factor: 1.831

Review 8.  Rewiring Host Signaling: Hepatitis C Virus in Liver Pathogenesis.

Authors:  Alessia Virzì; Armando Andres Roca Suarez; Thomas F Baumert; Joachim Lupberger
Journal:  Cold Spring Harb Perspect Med       Date:  2020-01-02       Impact factor: 5.159

9.  Superoxide Dismutase 1 Protects Hepatocytes from Type I Interferon-Driven Oxidative Damage.

Authors:  Anannya Bhattacharya; Ahmed N Hegazy; Nikolaus Deigendesch; Lindsay Kosack; Jovana Cupovic; Richard K Kandasamy; Andrea Hildebrandt; Doron Merkler; Anja A Kühl; Bojan Vilagos; Christopher Schliehe; Isabel Panse; Kseniya Khamina; Hatoon Baazim; Isabelle Arnold; Lukas Flatz; Haifeng C Xu; Philipp A Lang; Alan Aderem; Akinori Takaoka; Giulio Superti-Furga; Jacques Colinge; Burkhard Ludewig; Max Löhning; Andreas Bergthaler
Journal:  Immunity       Date:  2015-11-17       Impact factor: 31.745

10.  Molecular Signatures of Recurrent Hepatocellular Carcinoma Secondary to Hepatitis C Virus following Liver Transplantation.

Authors:  Trina Das; Deborah L Diamond; Matthew Yeh; Sajida Hassan; Janine T Bryan; Jorge D Reyes; James D Perkins
Journal:  J Transplant       Date:  2013-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.